Psoriatic Arthritis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drugs Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101066

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2016-2027
Base Year	2019
Forecast Period	2020-2027
Historical Period	2016-2018
Unit	Value (USD Billion)
Segmentation	By Drug Class Non-steroidal Anti-inflammatory Drugs (NSAIDS) Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) Others
	By Route of Administration Oral Parenteral Topical
	By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
	By Geography North America (the U.S., and Canada) Europe (the U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe) Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) The Middle East & Africa (South Africa, GCC and the Rest of the Middle East & Africa)